Latest filingAug 19, 2026Most recent Form 4
TVTX
Travere Therapeutics, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$63.2M5 sells
Net open-market-$63.2M1 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period9transactions
- S · Open-market sells · dominant5 · 56%
- M · Option exercise4 · 44%
Activity by reported role
A joint filing can contribute to multiple roles9transactions
- Director · dominant9 · 100%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (1)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeLyons Gary ACommon Stock · Direct
62,400Aug 18, 2026
Lyons Gary AStock option (right to buy) · Direct
0Aug 18, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- LA-$458.4k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
TVTX transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| TVTX | LYONS GARY A | DIR | exercise10b5-1 | 5.00k | $0 | M | −0.4% | 08/19 | 08/18 | |
| TVTX | LYONS GARY A | DIR | exercise10b5-1 | 5.00k | $0 | M | −0.4% | 08/19 | 08/17 | |
| TVTX | LYONS GARY A | DIR | sale10b5-1 | 900 | -$5.74M | S | −0.4% | 08/19 | 08/18 | |
| TVTX | LYONS GARY A | DIR | sale10b5-1 | 4.09k | -$25.9M | S | −0.4% | 08/19 | 08/18 | |
| TVTX | LYONS GARY A | DIR | exercise10b5-1 | 5.00k | $8.72M | M | −0.4% | 08/19 | 08/18 | |
| TVTX | LYONS GARY A | DIR | sale10b5-1 | 500 | -$3.20M | S | −0.4% | 08/19 | 08/17 | |
| TVTX | LYONS GARY A | DIR | sale10b5-1 | 2.60k | -$16.5M | S | −0.4% | 08/19 | 08/17 | |
| TVTX | LYONS GARY A | DIR | sale10b5-1 | 1.90k | -$11.8M | S | −0.4% | 08/19 | 08/17 | |
| TVTX | LYONS GARY A | DIR | exercise10b5-1 | 5.00k | $8.72M | M | −0.4% | 08/19 | 08/17 |
Travere Therapeutics, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Travere Therapeutics, Inc.?
LYONS GARY A.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Lyons Gary A reported a sale on Aug 18, 2026 valued at $5.74M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $632,845.97. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.